P. Lepelley

发表

Translocation t(10;17)(p13;q12) in two cases of acute nonlymphocytic leukemia with phagocytic activity of blasts. A new cytogenetic entity?

P. Fenaux, F. Bauters, J. Laï, 1989, Cancer genetics and cytogenetics.

NF-κB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome

G. Kroemer, P. Fenaux, V. Ribrag, 2005 .

NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome.

G. Kroemer, A. Coquelle, P. Fenaux, 2006, Blood.

Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation

B. Quesnel, C. Preudhomme, M. Vanrumbeke, 1996, British journal of haematology.

Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.

C. Bauters, S. Susen, B. Jude, 1994, Circulation.

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.

H. Dombret, A. Stamatoullas, P. Greenberg, 2008, Blood.

Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study

H. Dombret, A. Plesa, C. Preudhomme, 2019, Cancers.

Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.

B. Quesnel, C. Preudhomme, P. Fenaux, 1994, Leukemia.

Over‐expression of the MDM2 gene is found in some cases of haematological malignancies

B. Quesnel, D. Oscier, C. Preudhomme, 1994, British journal of haematology.

Inactivation of the p53 gene in leukemias and myelodysplastic syndrome (MDS) with 17p monosomy.

E. Wattel, C. Preudhomme, P. Fenaux, 1994, Leukemia.

Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.

E. Wattel, C. Preudhomme, P. Fenaux, 1995, Leukemia.

Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.

C. Preudhomme, P. Fenaux, A. Cosson, 1994, Leukemia.

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

E. Solary, E. Wattel, P. Fenaux, 1999, Leukemia.

P135 Has treatment with EPO+/-G-CSF an impact on progression to AML and survival in low/int-1-risk MDS? A comparison between French-EPO patients and the IMRAW database

H. Dombret, P. Greenberg, P. Fenaux, 2007 .

bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.

C. Preudhomme, P. Fenaux, A. Cosson, 1995, Leukemia.

myelodysplastic syndrome B constitutes a potential therapeutic target in high-risk κ NF-

G. Kroemer, A. Coquelle, P. Fenaux, 2011 .

NF- (cid:1) B constitutes a potential therapeutic target in high-risk myelodysplastic syndrome

G. Kroemer, A. Coquelle, P. Fenaux, 2006 .

Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide.

H. Dombret, A. Stamatoullas, L. Mannone, 2008, Leukemia research.

Fas/APO-1 (CD95) expression in myelodysplastic syndromes.

P. Fenaux, N. Grardel, A. Cosson, 1998, Leukemia & lymphoma.

Is apoptosis a massive process in myelodysplastic syndromes?

C. Preudhomme, P. Fenaux, N. Grardel, 1996, British journal of haematology.

Long‐term follow‐up of de novo myelodysplastic syndromes treated with intensive chemotherapy: incidence of long‐term survivors and outcome of partial responders

E. Wattel, C. Preudhomme, P. Fenaux, 1997, British journal of haematology.

Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia

V. Gouilleux-Gruart, X. Troussard, J. Lefrère, 2007, Leukemia & lymphoma.

195 Autologous bone marrow (ABMT) or peripheral blood stem cell (ABSCT) transplantation after intensive chemotherapy in myelodysplastic syndromes (MDS)

A. Stamatoullas, E. Solary, P. Fenaux, 1997 .

Very low incidence of p53 antibodies in adult non‐Hodgkin's lymphoma and multiple myeloma

T. Soussi, C. Preudhomme, P. Fenaux, 1998, British journal of haematology.

Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.

C. Preudhomme, P. Fenaux, N. Grardel, 1998, Leukemia & lymphoma.

Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?

C. Preudhomme, P. Fenaux, S. de Botton, 2002, Blood.

Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes

B. Quesnel, C. Preudhomme, P. Fenaux, 1994, British journal of haematology.

Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.

R. Lubin, C. Preudhomme, P. Fenaux, 1994, Leukemia.

Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.

B. Quesnel, C. Preudhomme, P. Fenaux, 1993, Leukemia.

Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes

C. Preudhomme, P. Fenaux, A. Cosson, 1995, British journal of haematology.

T-cell acute lymphoblastic leukemia occurring in the course of B cell chronic lymphocytic leukemia: a case report.

C. Preudhomme, P. Fenaux, M. Zandecki, 1995, Leukemia & lymphoma.

Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes.

B. Quesnel, E. Wattel, C. Preudhomme, 1993, Leukemia.

Translocation t(1;19)(q23;p13) in acute lymphoblastic leukemia. A report on six new cases and an unusual t(17;19)(q11;q13), with special reference to prognostic factors.

P. Fenaux, F. Bauters, J. Laï, 1989, Cancer genetics and cytogenetics.

Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.

P. Fenaux, F. Bauters, J. Jouet, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunological detection of myeloperoxidase in poorly differentiated acute leukemia

C. Preudhomme, P. Fenaux, A. Cosson, 1993, European journal of haematology.

Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype

B. Quesnel, C. Preudhomme, P. Fenaux, 2001, Leukemia.

Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis.

B. Quesnel, C. Preudhomme, E. Cornet, 2012, Leukemia research.

Total peroxidase deficiency in eosinophils: A report on twin sisters, one with a refractory anaemia

P. Fenaux, G. Torpier, M. Zandecki, 1987, European journal of haematology.

Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia

H. Dombret, A. Baruchel, F. Lacombe, 2018, Hematological oncology.

Cytogénétique Hématologique (GFCH) d'Hématologie Cellulaire (GFHC) and the Groupe Français de gene mutations: a report of 59 cases by the Groupe Français M0 AML, clinical and biologic features of the disease, includingAML1

O. Casasnovas, E. Macintyre, R. Berger, 2013 .

Brief report M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Franc¸ais d’He´matologie Cellulaire (GFHC) and the Groupe Franc¸ais de Cytoge´ne´tique He´matologique (GFCH)

O. Casasnovas, E. Macintyre, R. Berger, 2003 .

Refractory anaemia according to the FAB classification: A report on 69 cases

R. Beuscart, P. Fenaux, F. Bauters, 1988, European journal of haematology.

Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies

E. Clappier, H. Cavé, C. Preudhomme, 2009, Leukemia.

Philadelphia negative, BCR-ABL positive adult acute lymphoblastic leukemia (ALL) in 2 of 39 patients with combined cytogenetic and molecular analysis.

C. Preudhomme, P. Fenaux, M. Zandecki, 1993, Leukemia.

99 Expression of LRP and its correlation with other drug resistance proteins and outcome in myelodysplastic syndromes (MDS)

E. Wattel, C. Preudhomme, P. Fenaux, 1997 .

Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia

C. Preudhomme, Aline Renneville, J. Laï, 2008, Genes, chromosomes & cancer.

Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.

E. Wattel, P. Fenaux, F. Bauters, 1995, Leukemia.

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia

E. Macintyre, M. Béné, F. Garnache-Ottou, 2009, British journal of haematology.

Expression of the multidrug resistance‐associated protein in myelodysplastic syndromes

E. Wattel, C. Preudhomme, P. Fenaux, 2000, British journal of haematology.

Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.

E. Wattel, P. Fenaux, A. Cosson, 1999, Advances in experimental medicine and biology.

Congenital diserythropoietic anemia type I

P. Morel, P. Fenaux, T. Facon, 1990, Blut.

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).

O. Casasnovas, E. Macintyre, R. Berger, 2003, Blood.

A GEIL flow cytometry consensus proposal for quantification of plasma cells: Application to differential diagnosis between MGUS and myeloma

F. Durrieu, M. Béné, X. Leleu, 2011, Cytometry. Part B, Clinical cytometry.

Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients.

C. Preudhomme, P. Fenaux, M. Zandecki, 2008, Clinical and laboratory haematology.

[Waldenström's macroglobulinemia].

P. Morel, X. Leleu, B. Hivert, 2010, La Revue de medecine interne.

Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.

E. Macintyre, C. Preudhomme, P. Fenaux, 2002, Blood.

Detection of monocyte tissue factor after endotoxin stimulation: comparison of one functional and three immunological methods.

S. Susen, B. Jude, A. Cosson, 1995, Thrombosis research.

Congenital acute monoblastic leukemia with double translocation (8;16) (p11;p13) and (16;20) (q13;p13).

M. Zandecki, J. Laï, O. Chassaing, 1988, Nouvelle revue francaise d'hematologie.

Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells

C. Preudhomme, P. Fenaux, T. Facon, 1998, Leukemia.

The role of cardiovascular research and clinical training in health care reform.

E. Antman, M. Laks, C. Schmid, 1994, Circulation.

A case of refractory anemia with 17p− syndrome following azathioprine treatment for heart transplantation

B. Quesnel, C. Preudhomme, S. Depil, 2004, Leukemia.